retatrutide timing Starting Dose: Full Dosing Guide and What to Expect VisualAbstract: Retatrutide reduces body weight
Description
GLP-1 GLP-1 is secreted by the pancreas and by intestinal L-cells in response to glucose-induced insulin release (177, 178)

Its used for type 2 diabetes and has a recently approved cardiovascular label extension, and one oral semaglutide product in development for obesity and cardiovascular risk reduction

This drug is meant to be taken long-term

It is therefore not clear how much of the placebo effect resulted in the drug treatment outcome

Outcomes depend on adherence, dosing, and lifestyle factors

B12 supplementation may help if levels are low
